UBS O'Connor’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,523
Closed -$803K 411
2025
Q2
$803K Buy
14,523
+1,183
+9% +$56.8K 0.02% 246
2025
Q1
$645K Buy
+13,340
New +$559K 0.02% 214
2024
Q3
Sell
-68,231
Closed -$2.76M 587
2024
Q2
$2.36M Sell
68,231
-41,099
-38% -$1.2M 0.07% 173
2024
Q1
$3.16M Buy
109,330
+3,176
+3% +$86.4K 0.09% 121
2023
Q4
$2.43M Sell
106,154
-30,114
-22% -$527K 0.08% 148
2023
Q3
$2.27M Buy
136,268
+69,174
+103% +$1.34M 0.04% 223
2023
Q2
$1.85M Sell
67,094
-41,379
-38% -$1.04M 0.04% 310
2023
Q1
$2.49M Buy
+108,473
New +$1.82M 0.06% 236
2022
Q4
Sell
-232,820
Closed -$1.96M 249
2022
Q3
$1.96M Buy
232,820
+13,000
+6% +$123K 0.02% 628
2022
Q2
$1.74M Buy
+219,820
New +$2.66M 0.02% 682

Other funds holding PTGX